phloretin has been researched along with Diabetic Nephropathies in 2 studies
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phloretin is a dihydrochalcone flavonoid from natural plants, which has protective activities against oxidative stress and inflammation." | 1.72 | Phloretin ameliorates diabetic nephropathy by inhibiting nephrin and podocin reduction through a non-hypoglycemic effect. ( Cui, X; Jiang, J; Liu, J; Sun, M; Xia, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J | 1 |
| Sun, M | 1 |
| Xia, Y | 1 |
| Cui, X | 1 |
| Jiang, J | 1 |
| Shelke, V | 1 |
| Kale, A | 1 |
| Dagar, N | 1 |
| Habshi, T | 1 |
| Gaikwad, AB | 1 |
2 other studies available for phloretin and Diabetic Nephropathies
| Article | Year |
|---|---|
Phloretin ameliorates diabetic nephropathy by inhibiting nephrin and podocin reduction through a non-hypoglycemic effect.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Intrace | 2022 |
Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury.
Topics: Acute Kidney Injury; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ischemia; Mal | 2023 |